Fieldpoint Private Securities, LLC

SEC CIK: 0001706170
Latest filing: Aug 5, 2022

SEC filings (opens in a new tab)

NKTR holding history

Nektar Therapeutics in every 13F filed by Fieldpoint Private Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overview All 13F holders of NKTR Full Q2 2022 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of NKTR by Fieldpoint Private Securities, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−25−100.0%	Sold out	Holders
Q2 2021	25	$0	0.0%	00.0%	Unchanged	Holders
Q1 2021	25	$0	0.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.